Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 5 Breast Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasms 3 Melanoma 3 Leukemia, Myeloid, Acute 3 Leukemia 3 Carcinoma, Non-Small-Cell Lung 3 Myelodysplastic Syndromes 2 Lymphoma, Mantle-Cell 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hematologic Neoplasms 2 Craniopharyngioma 2 COVID-19 2 Burkitt Lymphoma 2 Arthritis, Rheumatoid 2 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Unresectable Pancreatic Carcinoma 1 Triple Negative Breast Neoplasms 1 Stroke 1 Sarcoma 1 Respiratory Tract Infections 1 Recurrence 1 Pulmonary Disease, Chronic Obstructive 1 Prostatic Neoplasms 1 Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1

Interventions

Bevacizumab 7 Talc 4 Pleurodesis 4 Thoracoscopy 3 Povidone-Iodine 3 Paclitaxel 3 Drug Therapy 3 Doxycycline 3 Docetaxel 3 Cisplatin 3 Chest Tubes 3 Carboplatin 3 aldesleukin 2 Thoracentesis 2 Taxes 2 Surveys and Questionnaires 2 Sodium Chloride 2 Silver Nitrate 2 Pharmaceutical Preparations 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Interleukin-2 2 High-Energy Shock Waves 2 Gemcitabine 2 Fentanyl 2 tocilizumab 1 talimogene laherparepvec 1 romidepsin 1 lipoplatin 1 cediranib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pleural Effusion, Malignant × tocilizumab × Clear all

NCT06016179 2025-05-22

RIOT2

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Phase 1 Recruiting

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡